| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2011 | 18β-Glycyrrhetinic acid derivatives induced mitochondrial-mediated apoptosis through reactive oxygen species-mediated p53 activation in NTUB1 cells | Lin K.-W.; Huang A.-M.; Hour T.-C.; Yang S.-C.; YEONG-SHIAU PU ; Lin C.-N. | Bioorganic and Medicinal Chemistry | 38 | 36 | |
| 2008 | Androgen receptor gene polymorphism may affect the risk of urothelial carcinoma | Liu C.-H.; Huang J.-D.; Huang S.-W.; Hour T.-C.; Huang Y.-K.; Hsueh Y.-M.; Chiou H.-Y.; Lee T.-C.; Jan K.-Y.; Chen C.-J.; YEONG-SHIAU PU | Journal of Biomedical Science | 12 | 9 | |
| 2011 | Anthraquinone derivatives induce G2/M cell cycle arrest and apoptosis in NTUB1 cells | Tu H.-Y.; Huang A.-M.; Teng C.-H.; Hour T.-C.; Yang S.-C.; YEONG-SHIAU PU ; Lin C.-N. | Bioorganic and Medicinal Chemistry | 19 | 16 | |
| 2014 | Anti-cancer effects of ursane triterpenoid as a single agent and in combination with cisplatin in bladder cancer | Lin K.-W.; Huang A.-M.; Lin C.-C.; Chang C.-C.; Hsu W.-C.; Hour T.-C.; YEONG-SHIAU PU ; Lin C.-N. | European Journal of Pharmacology | 19 | 15 | |
| 2011 | Antioxidant xanthone derivatives induce cell cycle arrest and apoptosis and enhance cell death induced by cisplatin in NTUB1 cells associated with ROS | Cheng J.-H.; Huang A.-M.; Hour T.-C.; Yang S.-C.; YEONG-SHIAU PU ; Lin C.-N. | European Journal of Medicinal Chemistry | 41 | 41 | |
| 2002 | Arsenic trioxide as a novel anticancer agent against human transitional carcinoma - Characterizing its apoptotic pathway | YEONG-SHIAU PU ; Hour T.-C.; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H. | Anti-Cancer Drugs | 58 | 48 | |
| 2000 | Characterization of chemoresistance mechanisms in a series of cisplatin-resistant transitional carcinoma cell lines | Hour T.-C.; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H.; CHANG-YAO HSIEH ; YEONG-SHIAU PU | Anticancer Research | 45 | 40 | |
| 2009 | Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma | YEONG-SHIAU PU ; CHAO-YUAN HUANG ; Kuo Y.-Z.; Kang W.-Y.; Liu G.-Y.; Huang A.-M.; HONG-JENG YU ; Lai M.-K.; Huang S.-P.; Wu W.-J.; Chiou S.-J.; Hour T.-C. | Journal of Biomedical Science | 31 | 29 | |
| 2004 | Characterization of molecular events in a series of bladder urothelial carcinoma cell lines with progressive resistance to arsenic trioxide | Hour T.-C.; CHAO-YUAN HUANG ; CHIA-CHI LIN ; Chen J.; Guan J.-Y.; Lee J.-M.; YEONG-SHIAU PU | Anti-Cancer Drugs | 24 | 23 | |
| 2013 | Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomy | Chang C.-F.; Pao J.-B.; Yu C.-C.; CHAO-YUAN HUANG ; Huang S.-P.; Yang Y.-P.; Huang C.-N.; Chang T.-Y.; You B.-J.; Lee H.-Z.; Hour T.-C.; Bao B.-Y. | Annals of Surgical Oncology | 16 | 15 | |
| 2001 | Cross-resistance and combined cytotoxic effects of paclitaxel and cisplatin in bladder cancer cells | YEONG-SHIAU PU ; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H.; Hour T.-C. | Journal of Urology | 19 | 18 | |
| 2002 | Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21WAF1/CIP1 and C/EBPβ expressions and suppressing NF-κB activation | Hour T.-C.; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H.; YEONG-SHIAU PU | Prostate | 124 | 109 | |
| 2012 | Cytotoxic and antioxidant constituents from Garcinia subelliptica | Lin K.-W.; Huang A.-M.; Yang S.-C.; Weng J.-R.; Hour T.-C.; YEONG-SHIAU PU ; Lin C.-N. | Food Chemistry | 31 | 26 | |
| 2002 | Cytotoxicity of arsenic trioxide to transitional carcinoma cells | YEONG-SHIAU PU ; Hour T.-C.; Chen J.; CHAO-YUAN HUANG ; Guan J.-Y.; Lu S.-H. | Urology | 25 | 32 | |
| 2006 | Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer | Hour T.-C.; YEONG-SHIAU PU ; CHIA-CHI LIN ; Huang S.-W.; Chen J.; Chiu A.W.; Chen C.-J.; CHAO-YUAN HUANG | Anticancer Research | 10 | 8 | |
| 2009 | Down regulation of ABCD1 in human renal cell carcinoma | Hour T.-C.; Kuo Y.-Z.; Liu G.-Y.; Kang W.-Y.; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; Wu W.-J.; Huang S.-P.; YEONG-SHIAU PU | International Journal of Biological Markers | 9 | 9 | |
| 2008 | Down-regulated expression of RhoA in human conventional renal cell carcinoma | YEONG-SHIAU PU ; Wang C.-W.; Liu G.-Y.; Kuo Y.-Z.; CHAO YUAN HUANG ; Kang W.-Y.; CHIA-TUNG SHUN ; CHIA-CHI LIN ; Wu W.-J.; Hour T.-C. | Anticancer Research | 5 | 5 | |
| 2015 | EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1) | Hour T.-C.; Chung S.-D.; Kang W.-Y.; Lin Y.-C.; Chuang S.-J.; Huang A.-M.; Wu W.-J.; Huang S.-P.; CHAO-YUAN HUANG ; YEONG-SHIAU PU | Archives of Toxicology | 43 | 38 | |
| 2006 | Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells | YEONG-SHIAU PU ; Hsieh M.-W.; Wang C.-W.; Liu G.-Y.; CHAO-YUAN HUANG ; CHIA-CHI LIN ; Guan J.-Y.; Lin S.-R.; Hour T.-C. | Biochemical Pharmacology | 38 | 35 | |
| 2012 | Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy | Huang C.-N.; Huang S.-P.; Pao J.-B.; Hour T.-C.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Wu P.-P.; CHAO-YUAN HUANG ; Hsieh C.-J.; Bao B.-Y. | Journal of Internal Medicine | 32 | 30 |
